Aptadir Therapeutics

About:

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

Website: https://aptadir.com

Top Investors: CDP Venture Capital, Evotec, Angelini Ventures

Description:

Aptadir Therapeutics is developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions.

Total Funding Amount:

$1.6M

Headquarters Location:

Milan, Lombardia, Italy

Founded Date:

2024-01-01

Contact Email:

info(AT)aptadir.com

Founders:

Annalisa Di Ruscio, Daniel G. Tenen, Marcin Kortylewski, Vittorio de Franciscis

Number of Employees:

1-10

Last Funding Date:

2024-09-24

IPO Status:

Private

Industries: